SBMF Online Payment ▶

test directorySearch Results

Click here to search again.


Test Name:
Chlamydia pneumoniae, by PCR


  • SBMF No:
    45602
  • Performance Lab Name:
    ARUP Laboratories
  • Test Mnemonic:
    CPNEUMOPCR
  • ABN:
    Required – Not FDA-Approved
  • CPT Code:
    87486
  • LOINC Code:
    19146-0; 34645-2
  • Ref Lab Test No:
    0060715
  • Also Known As:
    Chlamydophila pneumoniae
  • Spec Type:
    Respiratory specimen: nasal wash, nasopharyngeal swab, bronchoalveolar lavage (BAL), or pleural fluid
  • Spec Container:
    Sterile, leak-proof container
    Viral Transport Media (Microtest M4 or UTM)
  • Pref Vol:
    2.0 mL
  • Min Vol:
    Pediatric Collection: 1.0 mL
  • Spec Collect:
    Collect in sterile container or in viral transport media
  • Spec Process:
    Note specimen source on container label and test requisition
    Place each specimen in a separate, individually sealed bag
    Freeze and transport frozen
  • Spec Store Transport:
    Frozen
    Submit specimen according to Biological Substance, Category B, shipping guidelines
  • Spec Stability:
    8 hours room temperature (20-30°C)
    3 days refrigerated (2-8°C)
    1 month frozen (-20°C) – Do not use frost-free units that undergo repeated freeze/thaw cycles
  • Spec Reject:
    Dry swabs and leaking or nonsterile containers
    Respiratory aspirates in collection containers with tubing (sample tends to leak from these containers, compromising the specimen).
  • Methodology:
    Polymerase Chain Reaction (PCR)
  • Clinical Significance:
    Refer to:
    ARUP Consult | The Physician's Guide to Laboratory Test Selection and Interpretation
  • Reference Range:
    Chlamydia pneumoniae by PCR
    Negative – Chlamydia pneumoniae DNA not detected by PCR
    Positive – Chlamydia pneumoniae DNA detected by PCR
    Interpretive Data:
    A negative result does not rule out the presence of PCR inhibitors in the patient specimen or Chlamydia pneumoniae DNA concentrations below the level of detection by the assay.
  • Additional Test Info:

    This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.

    This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

  • Day Run:
    Mon, Wed, Fri
  • Time Reported:
    2-6 days
  • Test Type:
    INFECTIOUS ORGANISM